119 related articles for article (PubMed ID: 12064315)
1. Teaching adherence to substance users.
TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
[No Abstract] [Full Text] [Related]
2. How HIV drugs work 101.
Pietrandoni G
Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
[No Abstract] [Full Text] [Related]
3. Patient adherence, not viral load now most important in HIV therapy.
Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406
[No Abstract] [Full Text] [Related]
4. Another take on when to start and how to succeed.
Friedland GH
AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
[No Abstract] [Full Text] [Related]
5. Improved AIDS treatments bring life and hope--at a cost.
Brink S
US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336
[No Abstract] [Full Text] [Related]
6. Rescue regimens: the value of PI boosting.
Segal-Maurer S; Schütz M
Posit Aware; 2001; 12(6):35-7. PubMed ID: 11785478
[No Abstract] [Full Text] [Related]
7. Consider these initial combination regimens.
AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
[No Abstract] [Full Text] [Related]
8. The ever-changing HIV treatment landscape.
Berger DS
Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
[No Abstract] [Full Text] [Related]
9. Rescue regimens: the value of protease-inhibitor boosting.
Segal-Maurer S; Schütz M
Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
[No Abstract] [Full Text] [Related]
10. Protease inhibitors in children: combination therapy reduced death by two thirds.
James JS
AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
[No Abstract] [Full Text] [Related]
11. ABC in the news.
Carter M
IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
[No Abstract] [Full Text] [Related]
12. HIV's potent cocktail.
Lusky K
Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
[No Abstract] [Full Text] [Related]
13. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report.
Walsh JC; Dalton M; Gazzard BG
AIDS; 1998 Dec; 12(17):2361-3. PubMed ID: 9863888
[No Abstract] [Full Text] [Related]
14. New versions of antiretroviral guidelines contain some important changes.
Murphy MJ
Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
[No Abstract] [Full Text] [Related]
15. Once-daily therapies.
Carey D
J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
17. HIV integrase inhibitors show potent activity in clinical trials.
Winslow DL
AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
[No Abstract] [Full Text] [Related]
18. Anti-HIV drug update.
Proj Inf Perspect; 2000 Mar; (29):6-7. PubMed ID: 12769050
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
20. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
